These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564 [TBL] [Abstract][Full Text] [Related]
44. [FTLD/ALS as TDP-43 proteinopathies]. Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552 [TBL] [Abstract][Full Text] [Related]
45. Frontotemporal dementias: update on recent developments in molecular genetics and neuropathology. Liscić RM Arh Hig Rada Toksikol; 2009 Mar; 60(1):117-22. PubMed ID: 19329383 [TBL] [Abstract][Full Text] [Related]
46. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin. Hiji M; Takahashi T; Fukuba H; Yamashita H; Kohriyama T; Matsumoto M Acta Neuropathol; 2008 Aug; 116(2):183-91. PubMed ID: 18584184 [TBL] [Abstract][Full Text] [Related]
47. Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss. Kobayashi Z; Tsuchiya K; Arai T; Yokota O; Yoshida M; Shimomura Y; Kondo H; Haga C; Asaoka T; Onaya M; Ishizu H; Akiyama H; Mizusawa H J Neurol Sci; 2010 Nov; 298(1-2):70-7. PubMed ID: 20810131 [TBL] [Abstract][Full Text] [Related]
48. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other? Baloh RH Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957 [TBL] [Abstract][Full Text] [Related]
49. TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Roeber S; Mackenzie IR; Kretzschmar HA; Neumann M Acta Neuropathol; 2008 Aug; 116(2):147-57. PubMed ID: 18536926 [TBL] [Abstract][Full Text] [Related]
51. A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration. Nakamura M; Bieniek KF; Lin WL; Graff-Radford NR; Murray ME; Castanedes-Casey M; Desaro P; Baker MC; Rutherford NJ; Robertson J; Rademakers R; Dickson DW; Boylan KB Acta Neuropathol; 2015 Jul; 130(1):145-57. PubMed ID: 25917047 [TBL] [Abstract][Full Text] [Related]
52. Making the diagnosis of frontotemporal lobar degeneration. Bigio EH Arch Pathol Lab Med; 2013 Mar; 137(3):314-25. PubMed ID: 23451743 [TBL] [Abstract][Full Text] [Related]
53. Proteomic analysis of hippocampal dentate granule cells in frontotemporal lobar degeneration: application of laser capture technology. Gozal YM; Dammer EB; Duong DM; Cheng D; Gearing M; Rees HD; Peng J; Lah JJ; Levey AI Front Neurol; 2011; 2():24. PubMed ID: 21577247 [TBL] [Abstract][Full Text] [Related]
54. TDP-43 skeins show properties of amyloid in a subset of ALS cases. Robinson JL; Geser F; Stieber A; Umoh M; Kwong LK; Van Deerlin VM; Lee VM; Trojanowski JQ Acta Neuropathol; 2013 Jan; 125(1):121-31. PubMed ID: 23124365 [TBL] [Abstract][Full Text] [Related]
56. [Frontotemporal lobar degeneration (FTLD) - changes of its concept and classification based on aggregated proteins]. Nakano I Rinsho Shinkeigaku; 2012; 52(11):1218-20. PubMed ID: 23196569 [TBL] [Abstract][Full Text] [Related]
57. Frontotemporal lobar degeneration: diversity of FTLD lesions. Seilhean D; Bielle F; Plu I; Duyckaerts C Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575 [TBL] [Abstract][Full Text] [Related]